Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The primary function of muscle is to generate force or movement in response to a physiological stimulus. The human body contains three fundamentally different types of muscle adapted to specialized functions. Skeletal muscle is responsible for the voluntary movement of bones that underlies locomotion and work production. Skeletal muscle also controls the breathing cycle of the lungs via contraction of the diaphragm and functions as a pump assisting return of the venous blood supply to the heart. Cardiac muscle is specific to the heart as the biomechanical pump driving the delivery of blood to the lungs and tissues. Smooth muscle provides mechanical control of organ systems such as the digestive, urinary, and reproductive tracts as well as the blood vessels of the circulatory system and the airway passages of the respiratory system.
Contraction of muscles is initiated either by a chemical neurotransmitter or paracrine factor or by direct electrical excitation. All muscles transduce chemical energy released by hydrolysis of ATP into mechanical work. The unique physiological role of each of the three basic muscle types dictates inherent differences in the rate and duration of contraction, metabolism, fatigability, and ability to regulate contractile strength. For example, both skeletal and cardiac muscle must be capable of rapid force development and shortening. However, skeletal muscle must be able to maintain contractile force for relatively long periods. Cardiac muscle contracts only briefly with each heartbeat but must sustain this rhythmic activity for a lifetime. Smooth muscle, like skeletal muscle, must be able to regulate contraction over a wide range of force development and elastic changes in the size of organs such as the urinary bladder and uterus. In some tissues (e.g., sphincters), smooth muscle sustains contraction without fatigue for very long periods. Despite these differences, the trigger for muscle contraction is the same for all three types of muscle: a rise in the free cytosolic Ca 2+ concentration ([Ca 2+ ] i ).
This chapter describes the fundamental physiology of muscle excitation, the coupling of excitation to contraction, the molecular mechanism of contraction, the regulation of contraction, and the related issues of muscle diversity. We describe general molecular mechanisms shared by all muscle cells and contrast the unique features of skeletal, cardiac, and smooth muscle. Because molecular mechanisms specific to cardiac myocytes are best understood in the unique context of the heart as a pump, we discuss details of cardiac muscle physiology at greater depth in Chapter 22 .
The smallest contractile unit of skeletal muscle is a multinucleated, elongated cell called a muscle fiber or myofiber ( Fig. 9-1 ). A bundle of linearly aligned muscle fibers forms a fascicle. In turn, bundles of fascicles form a muscle, such as the biceps. The whole muscle is contained within an external sheath extending from the tendons called the epimysium. Fascicles within the muscle are enveloped by a sheath called the perimysium. Single muscle fibers within individual fascicles are surrounded by a sheath called the endomysium. The highly organized architecture of skeletal muscle fibers and connective tissue allows skeletal muscle to generate considerable mechanical force in a vectorial manner. Beneath the endomysium surrounding each muscle fiber is the plasma membrane of the muscle cell called the sarcolemma. An individual skeletal muscle cell contains a densely arranged parallel array of cylindrical elements called myofibrils. Each myofibril is essentially an end-to-end chain of regular repeating units—or sarcomeres —that consist of smaller interdigitating filaments called myofilaments; these myofilaments contain both thin filaments and thick filaments (see pp. 25–28 ).
All skeletal muscle is under voluntary or reflex control by motor neurons of the somatic motor system. Somatic motor neurons are efferent neurons with cell bodies located in the central nervous system (CNS). A single muscle cell responds to only a single motor neuron whose cell body—except for cranial nerves—resides in the ventral horn of the spinal cord. However, the axon of a motor neuron typically branches near its termination to innervate a few or many individual muscle cells. The group of muscle fibers innervated by all of the collateral branches of a single motor neuron is referred to as a motor unit. A whole muscle can produce a wide range of forces and a graded range of shortening by varying the number of motor units excited within the muscle. The innervation ratio of a whole skeletal muscle is defined as the number of muscle fibers innervated by a single motor neuron. Muscles with a small innervation ratio control fine movements involving small forces. For example, fine, high-precision movements of the extraocular muscles that control positioning movements of the eye are achieved via an innervation ratio of as little as ~3 muscle fibers per neuron. Conversely, muscles with a large innervation ratio control coarse movement requiring development of large forces. Postural control by the soleus muscle uses an innervation ratio of ~200. The gastrocnemius muscle, which is capable of developing large forces required in athletic activities such as jumping, has innervation ratios that vary from ~100 to ~1000.
As discussed on pp. 208–210 , a motor nerve axon contacts each muscle fiber near the middle of the fiber to form a synapse called the neuromuscular junction. The specialized region of sarcolemma in closest contact with the presynaptic nerve terminal is called the motor end plate. Although skeletal muscle fibers can be artificially excited by direct electrical stimulation, physiological excitation of skeletal muscle always involves chemical activation by release of acetylcholine (ACh) from the motor nerve terminal. Binding of ACh to the nicotinic receptor gives rise to a graded, depolarizing end-plate potential. An end-plate potential of sufficient magnitude raises the membrane potential to the firing threshold and activates voltage-gated Na + channels (Navs) in the vicinity of the end plate, triggering an action potential that propagates along the surface membrane.
As action potentials propagate along the surface membrane of skeletal and cardiac muscle fibers, they penetrate into the cell interior via radially oriented, tubular invaginations of the plasma membrane called transverse tubules or T tubules ( Fig. 9-2 ). T tubules plunge into the muscle fiber and surround the myofibrils at two points in each sarcomere: at the junctions of the A and the I bands. A cross section through the A-I junction shows a complex branching array of T tubules penetrating to the center of the muscle cell and surrounding the individual myofibrils. Along its length the tubule associates with two terminal cisternae, which are specialized regions of the sarcoplasmic reticulum (SR). The SR of muscle cells is a specialized version of the endoplasmic reticulum (ER) of noncontractile cells and serves as a storage organelle for intracellular Ca 2+ . The combination of the T-tubule membrane and its two neighboring cisternae is called a triad junction, or simply a triad. N9-1
The process by which electrical “excitation” of the surface membrane triggers an increase of [Ca 2+ ] i in muscle is known as excitation-contraction coupling or EC coupling.
The combination of the T-tubule membrane and its two neighboring cisternae is called a triad or triad junction; this structure plays a crucial role in the coupling of excitation to contraction in skeletal muscle.
Cardiac myocytes have a T-tubule network similar to that of skeletal muscle myofibers except that a single terminal cisterna of the SR forms a dyad junction with the T-tubule rather than a triad junction. Furthermore, T-tubules of cardiac myocytes are located at the Z lines separating sarcomeres rather than at the A-I band junctions.
Smooth muscle, in contrast, has more rudimentary and shallow invaginations of the plasma membrane called caveolae (see Fig. 9-15 ). Caveolae are considered to be a special form of membrane microdomain called lipid rafts that are enriched in glycosphingolipids and cholesterol and are involved in signal transduction. A peripheral SR compartment of smooth muscle encircles the plasma membrane in close proximity to the caveolae. A larger network of central SR runs along the long axis of the cell. The peripheral SR is involved in local Ca 2+ release and interaction with plasma membrane ion channels that mediate electrical excitability, whereas the central SR has a greater role in delivering Ca 2+ to intracellular myofilaments for contraction.
Although the ultimate intracellular signal that triggers and sustains contraction of skeletal, cardiac, or smooth-muscle cells is a rise in [Ca 2+ ] i , the three types of muscle cells differ substantially in the detailed mechanism by which a depolarization of the sarcolemmal membrane results in a rise in [Ca 2+ ] i . Ca 2+ can enter the cytoplasm from the extracellular space through voltage-gated ion channels, or alternatively, Ca 2+ can be released into the cytoplasm from the intracellular Ca 2+ storage reservoir of the SR. Thus, both extracellular and intracellular sources may contribute to the increase in [Ca 2+ ] i . However, the relative importance of these two sources of Ca 2+ varies among the different muscle types.
In skeletal muscle, as noted in the text, the L-type Ca 2+ channel (also known as the DHP receptor) in the T tubule directly couples to the SR Ca 2+ -release channel (also known as the ryanodine receptor, RYR1), which leads to Ca 2+ release from the SR and thus a rise in [Ca 2+ ] i .
In contrast to skeletal muscle, in heart and smooth muscle, Ca 2+ influx via the voltage-gated Ca 2+ channel Cav1.2 directly activates an RYR2 isoform, leading to Ca 2+ release from the SR and raising [Ca 2+ ] i . This mechanism of EC coupling known as Ca 2+ -induced Ca 2+ release (CICR) is quite different from the mechanical coupling mechanism of skeletal muscle. In heart and smooth muscle, colocalization of plasma membrane Cav channels with intracellular SR Ca 2+ -release channels allows for close coupling of Ca 2+ entry from the plasma membrane and Ca 2+ -activation of RYR Ca 2+ -release channels. In the CICR coupling mechanism, the action of Ca 2+ can be considered as analogous to that of a neurotransmitter or chemical messenger that diffuses across a synapse to activate an agonist-gated channel, but in this case the synapse is the intracellular diffusion gap of ~15 nm between surface Cav channels and intracellular RYR channels on the SR membrane. The CICR mechanism serves as a robust amplification system whereby local influx of Ca 2+ from small clusters of L-type Cav channels in the plasma membrane trigger the coordinated release of Ca 2+ , the activation signal for myofilament contraction, from high-capacity internal Ca 2+ stores of the SR.
In smooth muscle but not in cardiac muscle, other Ca 2+ -activated ion channels (e.g., Ca 2+ -activated K + channels, and Ca 2+ -activated Cl − channels) also participate in repolarization and regulation of contractile tone. Activation of smooth-muscle contraction also often involves the IP 3 receptor (IP 3 R), another Ca 2+ -release channel of the ER/SR membrane. In many smooth muscles, a variety of receptor agonists and chemical mediators are coupled to activation of phospholipase C (PLC). PLC activation results in cleavage of PIP 2 (phosphatidylinositol 4,5-bisphosphate) and production of IP 3 , a chemical messenger that activates IP 3 R-mediated Ca 2+ release (see p. 60 ).
The ultimate intracellular signal that triggers and sustains contraction of skeletal muscle cells is a rise in [Ca 2+ ] i . Ca 2+ can enter the cytoplasm from the extracellular space through voltage-gated ion channels or, alternatively, Ca 2+ can be released into the cytoplasm from the intracellular Ca 2+ storage reservoir of the SR. Thus, both extracellular and intracellular sources may contribute to the increase in [Ca 2+ ] i . The process by which electrical “excitation” of the surface membrane triggers an increase of [Ca 2+ ] i in muscle is known as excitation-contraction coupling or EC coupling.
The propagation of the action potential into the T tubules of the myofiber depolarizes the triad region of the T tubules, as discussed in the previous section, thereby activating L-type Ca 2+ channels (see pp. 190–193 ). These voltage-gated channels cluster in groups of four called tetrads ( Fig. 9-3 ) and have a pivotal role as the voltage sensor in EC coupling. Functional complexes of L-type Ca 2+ channels contain the α 1 -subunit of the voltage-gated Ca 2+ channel (i.e., Cav1.1) as well as the accessory α 2 -δ, β, and γ subunits (see Fig. 7-12 B ). The L-type Ca 2+ channel is also often referred to as the DHP receptor because it is inhibited by a class of antihypertensive and antiarrhythmic drugs known as dihydropyridines or calcium channel blockers. Depolarization of the T-tubule membrane produces conformational changes in each of the four Cav1.1 channels of the tetrad, resulting in two major effects. First, the conformational changes open the Cav1.1 channel pore, which allows electrodiffusive Ca 2+ entry. Second, and more importantly in skeletal muscle, the voltage-driven conformational changes in the four Cav1.1 channels mechanically activate each of the four directly coupled subunits of another channel—the Ca 2+ -release channel located in the portion of the terminal cisternae of the SR membrane that faces the T tubule (see Fig. 9-3 ).
The SR Ca 2+ -release channel (see Fig. 6-20 W ) has a homotetrameric structure quite different from that of the T-tubule Cav1.1 channel. This SR Ca 2+ -release channel is also known as the ryanodine receptor (RYR) because it is inhibited by the plant alkaloid ryanodine —an important tool in characterizing RYRs. In contrast, another plant alkaloid, caffeine, which is present in coffee, activates RYRs by increasing opening probability. N9-2 RYRs are the largest known channel proteins, with a molecular mass of ~550 kDa for the monomer, or ~2.1 MDa for a homotetramer. Each of the four subunits of these channels has a large extension—also known as a foot—that projects into the cytosol (see Fig. 9-3 ).
As noted on page 230 of the text, the plant alkaloid caffeine, which is present in coffee, activates RYRs by increasing opening probability. Caffeine is often used experimentally as a research tool to open RYRs and deplete SR Ca 2+ stores in muscle, but this effect is not related to the potent CNS stimulant effects of caffeine, which are the result of its action as an antagonist of CNS adenosine receptors (see Fig 13-14 B ).
In skeletal muscle, where the Ca 2+ -release channels are of the RYR1 subtype, RYR1 tetramers line up in two rows in the SR membrane. In the T-tubule membrane, half as many Cav1.1 channel tetrads are similarly aligned but are spaced such that they make intracellular contact with every other RYR1 in an alternating “double checkerboard” pattern. The monomer foot domain of each of the four RYR1 subunits is complementary to the cytoplasmic projection of one of the four Cav1.1 channels in a tetrad on the T tubule (see Fig. 9-3 ). The precise geometrical proximity of these two proteins as well as the ability of both DHP and ryanodine to block muscle contraction indicates that mechanical interactions between these two different Ca 2+ channels underlie EC coupling in skeletal muscle. Further evidence for a direct physical interaction between Cav1.1 and RYR1 is the observation that many cycles of excitation and contraction can occur in complete absence of extracellular Ca 2+ . Moreover, Cav1.1 channels in the closed state physically inhibit the opening of RYR1 channels and thereby prevent the spontaneous release of SR Ca 2+ in the nonactivated, resting state. Thus, EC coupling in skeletal muscle is an electromechanical process involving a voltage-induced Ca 2+ release mechanism.
After depolarization of the L-type Ca 2+ channel on the T-tubule membrane and mechanical activation of the Ca 2+ -release channel in the SR, Ca 2+ stored in the SR rapidly leaves through the Ca 2+ -release channel. When imaged using a fluorescent Ca 2+ indicator, the rapid and transient rise in local [Ca 2+ ] i —from clusters of RYR channels—appears as a spark. N9-3 This increase in [Ca 2+ ] i activates troponin C, initiating formation of cross-bridges between myofilaments, as described below. EC coupling in skeletal muscle thus includes the entire process we have just described, beginning with the depolarization of the T-tubule membrane to the initiation of the cross-bridge cycle of contraction.
The use of advanced fluorescent Ca 2+ indicator dyes and confocal microscopy to image Ca 2+ signaling in muscle cells has revealed a variety of elementary events observed as brief bursts of fluorescence corresponding to a transient and highly localized increase in intracellular Ca 2+ . Detailed biophysical studies of these events, termed Ca 2+ sparks, has helped to refine understanding of EC coupling in skeletal, cardiac, and smooth-muscle cells.
Ca 2+ sparks were first characterized in cardiac myocytes and later also described in smooth muscle and skeletal muscle. Such spark events can be observed in resting cardiac myocytes loaded with a fluorescent Ca 2+ dye indicator such as fluo-3 ( eFig. 9-1 A ). The spark is a brief increase in fluorescence intensity corresponding to Ca 2+ binding to the dye resulting from a local and rapid increase in Ca 2+ concentration that rises to a peak within ~10 ms and decays within ~50 ms (see eFig. 9-1 B ). Such spontaneous sparks in cardiac myocytes are due to the small opening probability of SR RYR Ca 2+ -release channels that depends upon [Ca 2+ ] in the cytoplasm and SR lumen. Biophysical analysis indicates that a single spark event corresponds to the simultaneous opening of a cluster of Ca 2+ -release channels, termed calcium release units (CRUs), that may represent the opening of ~10 to 100 RYR channels, depending on the recording conditions and preparation. Although visual resolution of Ca 2+ sparks generally requires low activation conditions of Ca 2+ release, they can be observed in single cardiac myocytes activated by a depolarizing voltage pulse at the leading edge of a transient rise of [Ca 2+ ] i (see eFig. 9-1 A ).
eFigure 9-1 C shows a series of Ca 2+ sparks from a cardiac myocyte imaged by a line scan of a confocal microscope oriented along the long axis of the cell. The recording shows that synchronized voltage-activated Ca 2+ sparks appear at the locations of T tubules at a spacing of ~1.8 µm apart. Such experiments have shown that the macroscopic or global increase in cytoplasmic [Ca 2+ ] in muscle cells is the result of the stochastic summation of many individual spark events corresponding to localized bursts of intracellular Ca 2+ release. Studies of Ca 2+ sparks have also confirmed that voltage-activated mechanical coupling underlies EC mechanisms in skeletal muscle, whereas Ca 2+ -induced Ca 2+ release underlies these mechanisms in cardiac and smooth muscle.
Due to the tight voltage control of Ca 2+ release and termination by brief ~2-ms Na + action potentials in mammalian skeletal muscle, classical Ca 2+ sparks in these striated muscle cells can be resolved only after strenuous exercise of the muscle and under certain nonphysiological and pathological conditions. This implies that spontaneous opening of RYRs in skeletal muscle is suppressed by mechanical linkage to Cav channels in the resting state and that mechanical EC coupling of mammalian skeletal muscle involves fine temporal and voltage control of Ca 2+ release, which presumably facilitates precise control of many body movements.
Although we have stressed that EC coupling in skeletal muscle primarily involves direct mechanical coupling between the L-type Ca 2+ channel in the T-tubule membrane and the Ca 2+ -release channel of the SR, N9-1 other mechanisms modulate the activity of RYR1. For example, RYR1 is subject to regulation by cytoplasmic Ca 2+ , Mg 2+ , ATP, and calmodulin (CaM) as well as protein kinases such as protein kinase A (PKA; see p. 57 ) and Ca 2+ -calmodulin–dependent kinase II (CaMKII; see p. 60 ). In the fight-or-flight response (see p. 347 ), the sympathetic autonomic nervous system activates β-adrenergic receptors, causing PKA-mediated phosphorylation of RYR1 and other muscle proteins; this results in faster and larger increases in cytoplasmic Ca 2+ , and thus stronger skeletal muscle contraction ( Box 9-1 ).
Ca 2+ channels have been linked to a large variety of genetic defects of skeletal muscle. In mice, an interesting mutation results in muscular dysgenesis, or failure of normal skeletal muscle to develop. These mice lack a functional Ca 2+ channel α 1 subunit in their skeletal muscle. They die shortly after birth, but their cultured muscle cells provide an assay system to investigate the mechanism of EC coupling. Contraction of such defective muscle cells can be rescued by expression of cloned genes for either the skeletal Cav1.1 ( CACNA1S gene) or the cardiac Cav1.2 ( CACNA1C gene) L-type Ca 2+ channels. A key distinguishing feature of EC coupling in normal skeletal muscle versus cardiac muscle is the requirement for extracellular Ca 2+ in cardiac muscle (see pp. 242–243 ) but not in skeletal muscle (see pp. 242–243 ). N9-1 Indeed, when the rescue is accomplished with skeletal Cav1.1, contraction does not require extracellular Ca 2+ . On the other hand, when the rescue is accomplished with cardiac Cav1.2, contraction does require extracellular Ca 2+ . Such studies provide strong support for the concept that EC coupling (1) in skeletal muscle involves direct mechanical coupling of Cav1.1 to the RYR1 but (2) in cardiac muscle involves Ca 2+ entry through Cav1.2 channels, which causes Ca 2+ -induced Ca 2+ release (see pp. 242–243 ). Experiments with chimeric cardiac and skeletal Cav channel isoforms have shown that the intracellular linker region between domains II and III (see Fig. 7-12 B ) determines whether EC coupling is of the skeletal or cardiac type.
Hypokalemic periodic paralysis (not to be confused with hyper kalemic periodic paralysis, discussed in Box 7-1 ) is an autosomal dominant muscle disease of humans. Affected family members have a point mutation in the CACNA1S gene encoding the skeletal Cav1.1, located in transmembrane segment S4 of domain II. This finding explains the basis for a human disorder involving defective EC coupling of skeletal muscle.
Myofilaments are of two types: thick filaments composed primarily of a protein called myosin and thin filaments largely composed of a protein called actin (see pp. 25–28 ). The sarcomere is defined as the repeating unit between adjacent Z disks or Z lines ( Fig. 9-4 A, B ). A myofibril is thus a linear array of sarcomeres stacked end to end. The highly organized sarcomeres within skeletal and cardiac muscle are responsible for the striped or striated appearance of muscle fibers of these tissues as visualized by various microscopic imaging techniques. Thus, both skeletal muscle and cardiac muscle are referred to as striated muscle. In contrast, smooth muscle lacks striations because actin and myosin have a less regular pattern of organization in these myocytes.
In striated muscle, thin filaments —composed of actin—are 5 to 8 nm in diameter and 1 µm in length. The plus end of the thin filaments attach to opposite faces of a dense disk known as the Z disk (see Fig. 9-4 B ), which is perpendicular to the axis of the myofibril and has the diameter of the myofibril. Cross-linking the antiparallel thin filaments at the Z disk are α-actinin proteins. Each α-actinin is a rod-shaped antiparallel homodimer, 35 nm long and belonging to the spectrin family of actin-binding proteins. Two large proteins, titin and nebulin, are also tethered at the Z disks, as are other diverse proteins thought to be involved in stretch sensing and signal communication to the nucleus. Not only do Z disks tether the thin filaments of a single myofibril together, but connections between the Z disks also tether each myofibril to its neighbors and align the Z disks and thus the sarcomeres. In summary, Z disks have an important protein-organizing and tension-bearing role in the sarcomere structure.
The thick filaments —composed of myosin—are 10 to 15 nm in diameter and, in striated muscle, 1.6 µm in length (see Fig. 9-4 B ). They lie between and partially interdigitate with the thin filaments. This partial interdigitation results in alternating light and dark bands along the axis of the myofibril. The light bands, which represent regions of the thin filament that do not overlap with thick filaments, are known as I bands because they are isotropic to polarized light as demonstrated by polarization microscopy. The Z disk is visible as a dark perpendicular line at the center of the I band. The dark bands, which represent the myosin filaments, are known as A bands because they are anisotropic to polarized light. When the A band is viewed in cross section where the thick and thin filaments overlap, six thin filaments (actin) are seen to surround each thick filament (myosin) in a tightly packed hexagonal array (see Fig. 9-4 C ). During contraction, the I bands (nonoverlapping region of actin) shorten, while the A bands (myosin) do not change in length. This observation led to the idea that an energy-requiring ratcheting mechanism causes the thick and thin filaments to slide past each other—the sliding filament model of muscle contraction.
The backbone of the thin filament is a right-handed, two-stranded helix of noncovalently polymerized actin molecules, forming filamentous or F-actin ( Fig. 9-5 A ). N9-4 The fundamental unit is a supramolecular helix with a total of 13 molecules in the two strands and a length of ~36 nm. The muscle thin filament is an association of F-actin with two important regulatory actin-binding proteins: tropomyosin and the troponin complex.
Actin is perhaps the most abundant and highly conserved protein in eukaryotic cells. It is engaged in numerous protein-protein cytoskeletal interactions in the cytoplasm. The 43-kDa, 375-residue, soluble monomer form of actin is called G-actin. Aside from other cellular forms of cytoskeletal actin (see p. 25 ), there are three human isoforms of α-actin involved in muscle contraction that correspond to separate actin genes expressed in skeletal muscle (ACTA1), smooth muscle (ACTA2), and cardiac muscle (ACTC1). As noted beginning on pages 25–28 , binding and hydrolysis of ATP controls polymerization of G-actin into the filamentous form of actin (F-actin) by sequential addition of actin monomers at the plus end of the molecule. Each actin molecule in F-actin interacts with four other actin molecules. The fundamental unit is a supramolecular helix (a double strand) with a total of 13 molecules in the two strands, and a length of ~36 nm (see Fig. 9-5 A ).
The tropomyosin monomer of striated muscle is an α-helical protein of 284 amino acids, consisting of seven pseudo-repeats of ~40 residues along the length of the molecule. The pseudo-repeats of the monomer determine its linearly coiled shape and define the binding to seven actin monomers along the thin filament. Two tropomyosin monomers form a dimer aligned in parallel and wound about each other in a coiled-coil structure. Two such tropomyosin dimers flank each supramolecular helix of actin (see Fig. 9-5 A ). Overlapping head-to-tail contacts between two tropomyosin dimers produce two nearly continuous double-helical filaments that shadow the actin double helix. As we describe below, tropomyosin acts as a gatekeeper in regulating the binding of myosin head groups to actin.
Troponin or the troponin complex is a heterotrimer consisting of the following:
Troponin T (TnT or TNNT), which binds to a single molecule of t ropomyosin
Troponin C (TnC or TNNC), which binds Ca 2+ . Troponin C is closely related to another Ca 2+ -binding protein, calmodulin (see p. 60 ).
Troponin I (TnI or TNNI), which binds to actin and inhibits contraction.
Thus, each troponin heterotrimer interacts with a single tropomyosin molecule, which in turn interacts with seven actin monomers. The troponin complex also interacts directly with the actin filaments. The coordinated interactions of troponin, tropomyosin, and actin allow the binding of actin and myosin to be regulated by changes in [Ca 2+ ] i .
Like actin thin filaments, thick filaments are also an intertwined complex of proteins (see Fig. 9-5 B ). In fast skeletal muscle, the thick filament is a bipolar superassembly of several hundred myosin II molecules, which are part of a larger family of myosins (see p. 25 ). Myosin II is responsible for ATP-dependent force generation in all types of myocytes. The myosin II molecule is a pair of identical heterotrimers, each composed of a myosin heavy chain (MHC), and two myosin light chains (MLCs). One MLC is an essential light chain (ELC or MLC-1), N9-5 and the other is a regulatory light chain (RLC or MLC-2). Both the MHCs and MLCs vary among muscle types ( Table 9-1 ).
SKELETAL SLOW (TYPE I) | SKELETAL FAST OXIDATIVE (TYPE IIa) | SKELETAL FAST FATIGABLE (TYPE IIx/IIb) | CARDIAC | SMOOTH | |
---|---|---|---|---|---|
Myosin heavy chain | MHC-I (MYH1) and βMHC (MYH7) | MHC-IIa (MYH2) | MHC-IIb (MYH4) , MHC-IIx (MYH1) | αMHC † (MYH6) and βMHC (MYH7) | MHC-SM1, MHC-SM2 (MYH11) |
Myosin light chain (essential) | MLC-1aS, MLC-1bS (MYL3) | MLC-1f, MLC-3f (MYL1) | MLC-1f, MLC-3f (MYL1) | MLC-1v, MLC-1a (MYL3) | MLC-17a, MLC-17b (MYL6) |
Myosin light chain (regulatory) | MLC-2 (MYL2) | MLC-2fast (MYLPF) | MLC-2fast (MYLPF) | MLC-2v (MYL2), MLC-2a (MYL7) | MLC-2c (MYL9) |
SR Ca-ATPase | SERCA2a (ATP2A2) | SERCA1 (ATP2A1) | SERCA1 (ATP2A1) | SERCA2a (ATP2A2) | SERCA2a, SERCA2b (b > > > a) (ATP2A2) |
Phospholamban | Present | Absent | Absent | Present | Present |
Calsequestrin | CSQ1, CSQ2 | CSQ1 | CSQ1 | CSQ2 | CSQ2, CSQ1 |
Ca 2+ release mechanisms | RYR1, Ca 2+ -release channel or ryanodine receptor (RYR1) | RYR1 (RYR1) | RYR1 (RYR1) | RYR2 (RYR2) | IP 3 R1, IP 3 R2, IP 3 R3 (ITPR1, ITPR2, ITPR3) RYR3 (RYR3) |
Ca 2+ sensor | Troponin C 1 (TNNC1) | Troponin C 2 (TNNC2) | Troponin C 2 (TNNC2) | Troponin C 1 (TNNC1) | CaM (multiple isoforms) |
† In normal adult ventricular muscle, αMHC is the dominant form.
For historical reasons, the parts of the myosin II molecule in muscle often have more than one name.
Myosin heavy chains (MHCs) consist of the following:
The N-terminal head
A neck or lever (or lever arm) or linker or hinge
The C-terminal rod or tail
Essential myosin light chains ( ELCs or MLC-1 ) are also called alkali chains.
Regulatory myosin light chains ( RLCs or MLC-2 ).
A myosin heavy chain molecule has ~2000 amino acids in three regions: N9-5 an N-terminal head region, a neck, and a C-terminal rod. The α-helical rod portions of two MHCs wrap around each other to form a dimer; these dimers self-assemble into thick filaments. At the neck regions, the two MHCs of the dimer flare apart, leading to the two globular heads. Each MHC head has, at its tip, several loops that bind actin and, at its middle, a nucleotide site for binding and hydrolyzing ATP.
The essential light chain and regulatory light chain —both structurally related to the CaM superfamily—bind to and mechanically stabilize the α-helical neck region. The phosphorylation of RLC by myosin light-chain kinases (MLCKs) —members of the CaMK family—enhances myosin cross-bridge interactions. Phosphatases have the opposite effect. In skeletal muscle, this phosphorylation is an important mechanism for force potentiation. Figure 9-6 illustrates how Ca 2+ triggers the interaction between a thin filament and a myosin head group from a thick filament.
Running alongside the thick filaments of skeletal muscle is a protein named titin —the largest known protein, with ~25,000 amino acids (~3 MDa). The linear titin molecule spans one half the length of a sarcomere, with its N terminus tethered in the Z disk and its C terminus in the M line (see Fig. 9-4 B ). Within the M line are other proteins that cross-link the antiparallel myosin molecules at the middle of the thick filament. Titin—the elastic filament of sarcomeres—includes ~300 immunoglobulin-like domains that appear to unfold reversibly upon stretch.
Nebulin is another large protein (600 to 900 kDa) of muscle that runs from the Z disk along the actin thin filaments. Nebulin interacts with actin and controls the length of the thin filament; it also appears to function in sarcomere assembly by contributing to the structural integrity of myofibrils.
The fundamental process of skeletal muscle contraction involves a biochemical cycle, called the cross-bridge cycle, that occurs in six steps ( Fig. 9-7 ). We start the cycle in the absence of both ATP and ADP, with the myosin head rigidly attached to an actin filament. In a corpse soon after death, the lack of ATP prevents the cycle from proceeding further; this leads to an extreme example of muscle rigidity—called rigor mortis—that is limited only by protein decomposition.
Step 1: ATP binding. ATP binding to the head of the MHC reduces the affinity of myosin for actin, which causes the myosin head to release from the actin filament. If all cross-bridges in a muscle were in this state, the muscle would be fully relaxed.
Step 2: ATP hydrolysis. The breakdown of ATP to ADP and inorganic phosphate (P i ) occurs on the myosin head; the products of hydrolysis are retained within the myosin active site. As a result of hydrolysis, the myosin head/neck pivots into a “cocked” position in which the head/neck are more colinear with the rod. This pivot causes the tip of the myosin head to move ~11 nm along the actin filament so that it now lines up with a new actin monomer two monomers farther along the actin filament. N9-6 If all cross-bridges in a muscle were in this state, the muscle would be fully relaxed.
The force of a single cross-bridge cycle has been measured directly. Finer, Simmons, and Spudich used optical tweezers to manipulate a single actin filament and to place it in proximity to a myosin molecule immobilized on a bead ( eFig. 9-2 A ). With the use of video-enhanced microscopy these investigators were able to detect movements of the actin filament as small as 1 nm. The optical tweezers could also exert an adjustable force opposing movement of the actin filament. When the tweezers applied only a small opposing force and the experiment was conducted in the presence of ATP, the researchers observed that the actin moved over the myosin bead in step-like displacements of 11 nm. This observation, made under “microscopically isotonic” conditions, suggests that the quantal displacement of a single cross-bridge cycle is ~11 nm (see eFig. 9-2 B ). When the tweezers applied a force sufficiently large to immobilize the actin filament, the investigators observed step-like impulses of force that averaged ~5 pN (see eFig. 9-2 C ). This observation, made under “microscopically isometric” conditions, suggests that the quantal force developed during a single cross-bridge cycle is ~5 pN. Interestingly, these isometric force impulses lasted longer when the ATP concentration was lower. This last finding is consistent with the notion that ATP binding to myosin must occur to allow detachment of the cross-bridges (step 1 in the cycle in Fig. 9-7 ).
Step 3: Weak cross-bridge formation. The cocked myosin head now binds loosely to a new position on the actin filament, scanning for a suitable binding site. Recall that six actin filaments surround each thick filament.
Step 4: Release of P i from the myosin. Dissociation of P i from the myosin head triggers an increased affinity of the myosin-ADP complex for actin—the strong cross-bridge state. The transition from weak to strong binding is the rate-limiting step in the cross-bridge cycle.
Step 5: Power stroke. A conformational change causes the myosin neck to rotate around the myosin head, which remains firmly fixed to the actin. This bending pulls the rod of the myosin, drawing the actin and myosin filaments past one another by a distance of ~11 nm. The myosin head/neck is now angled with respect to the rod. At the macroscopic level, this activity pulls the Z lines closer together and shortens the sarcomere, with concurrent force generation.
Step 6: ADP release. Dissociation of ADP from myosin completes the cycle, and the actomyosin complex is left in a rigid, “attached state.” The relative positions of the actin versus the myosin head, neck, and rod remain the same until another ATP molecule binds and initiates another cycle (step 1).
The ADP–free myosin complex (“Attached State” in Fig. 9-7 ) would quickly bind ATP at the concentrations of ATP normally found within cells. Each round of the cross-bridge cycle consumes one molecule of ATP; we discuss the regeneration of ATP in muscle beginning on pages 1208–1209 . If unrestrained, this cross-bridge cycling would continue until the cytoplasm is depleted of ATP—rigor mortis.
The biochemical steps of the cross-bridge cycle reveal that [ATP] i does not regulate the cross-bridge cycle of actin-myosin interaction. In skeletal and cardiac muscle, temporal control of the cycle of contraction occurs at the third step by prevention of cross-bridge formation until the tropomyosin moves out of the way in response to an increase in [Ca 2+ ] i —as we will see in the next section.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here